Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 162 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL130253, AR067294, U54 HD 087351
Welch Foundation
Grant: 1-0025
NICHD NIH HHS
Grant: U54 HD087351
NICHD NIH HHS
Grant: P50 HD087351
NIAMS NIH HHS
Grant: R01 AR067294
NHLBI NIH HHS
Grant: R01 HL130253
National Institutes of Health
Grant: 5R01HL130253-06
Deciphering the role of a novel micropeptide in cardiac function and dysfunction
National Institutes of Health
Grant: 1U54HD087351-01
Myoediting Core
National Institutes of Health
Grant: 5R01AR067294-02
Molecular Dissection of Myoblast Fusion In Muscle Development and Regeneration
National Institutes of Health
Grant: 5U54HD087351-05
Myoediting of Duchenne muscular dystrophy
FWCI
8.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Removal of a partial genomic duplication restores synaptic transmission and behavior in the MyosinVA mutant mouse Flailer
Additional file 1 of Removal of a partial genomic duplication restores synaptic transmission and behavior in the MyosinVA mutant mouse Flailer
Additional file 3 of Removal of a partial genomic duplication restores synaptic transmission and behavior in the MyosinVA mutant mouse Flailer
Additional file 3 of Removal of a partial genomic duplication restores synaptic transmission and behavior in the MyosinVA mutant mouse Flailer